The Company has applied for listing of the bonds on the corporate bond list at Nasdaq Stockholm. The bonds will be admitted to trading on or about March 14, 2023.
In connection with this the Company has prepared a prospectus. The prospectus has been approved by the Swedish Financial Supervisory Authority. The Prospectus will be available on the Financial Supervisory Authority's website (www.fi.se) and on the Company's website (www.addvisegroup.com).
For additional information, please contact:
Rikard Akhtarzand, CEO
+46 765-25 90 71
Hanna Myhrman, General Counsel
+46 709-82 92 23
About ADDvise Group
ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business - both geographically and product wise. ADDvise Group's shares are listed on Nasdaq First North Premier and Mangold Fondkommission AB, +46 8 503 015 50,